tirzepatide hims compounded & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over sustainable wellness goals. Hims is in the crosshairs. – Hims rises as FDA considers
Pay in 4 interest-free payments of $6.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12

























